SYSTEMATIC REVIEW OF THE GLOBAL ECONOMIC BURDEN OF RARE DISEASES
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This project is a systematic review aimed at evaluating the global economic burden of rare diseases on healthcare systems and society. The review will synthesize evidence from cost-of-illness and budget impact analysis studies published between 2016 and 2025, focusing on direct medical, direct non-medical, and indirect costs. A comprehensive search will be conducted in MEDLINE, Embase, LILACS, and Web of Science, without language restrictions. Study selection and data extraction will be performed independently by reviewers following PRISMA-P guidelines. This study seeks to provide an up-to-date synthesis of the economic impact of rare diseases to support evidence-based decision-making and health policy development.
Fields of Study & Subjects
Health Systems
Economic Evaluations
Quality of Life
Economic and Financial Impacts of Cancer
Genomics and Rare Diseases
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint